Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joseph Wu

Showing results (91-100 of 120) with videos related to

Pageof 12
Sort By:
Journal of Crohn'S & Colitis|May 3, 2024
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical ProgrammeMiguel Regueiro, Britta Siegmund, Andres J Yarur, et al.
Annals of the Rheumatic Diseases|April 28, 2021
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled studyAtul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, et al.
Inflammatory Bowel Diseases|June 20, 2024
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical ProgramVipul Jairath, David T Rubin, Bram Verstockt, et al.
BMJ Global Health|May 29, 2023
Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trialTakaaki Kobayashi, Hana Tomoi, Yuka Nishina, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetesGui-Bai Liang, Xiaoxia Qian, Dennis Feng, et al.
Vaccines|July 29, 2023
Coronavirus Disease 2019 (COVID-19) Reinfection Rates in Malawi: A Possible Tool to Guide Vaccine Prioritisation and Immunisation PoliciesMaster R O Chisale, Frank Watson Sinyiza, Paul Uchizi Kaseka, et al.
Trials|October 13, 2017
The added value of a mobile application of Community Case Management on referral, re-consultation and hospitalization rates of children aged under 5 years in two districts in Northern Malawi: study protocol for a pragmatic, stepped-wedge cluster-randomized controlled trialVictoria Hardy, Yvonne O'Connor, Ciara Heavin, et al.
Patterns (New York, N.Y.)|September 5, 2024
Concepts and applications of digital twins in healthcare and medicineKang Zhang, Hong-Yu Zhou, Daniel T Baptista-Hon, et al.
Advances in Rheumatology (London, England)|December 19, 2024
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitisAtul Deodhar, Servet Akar, Jeffrey R Curtis, et al.
The Lancet. Gastroenterology & Hepatology|May 17, 2025
Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trialEvan S Dellon, Margaret H Collins, Albert J Bredenoord, et al.
Pageof 12

Showing results (91-100 of 120) with videos related to

Sort By:
Pageof 12
Journal of Crohn'S & Colitis|May 3, 2024
Etrasimod for the Treatment of Ulcerative Colitis: Analysis of Infection Events from the ELEVATE UC Clinical ProgrammeMiguel Regueiro, Britta Siegmund, Andres J Yarur, et al.
Annals of the Rheumatic Diseases|April 28, 2021
Tofacitinib for the treatment of ankylosing spondylitis: a phase III, randomised, double-blind, placebo-controlled studyAtul Deodhar, Paula Sliwinska-Stanczyk, Huji Xu, et al.
Inflammatory Bowel Diseases|June 20, 2024
The Effect of Etrasimod on Fecal Calprotectin and High-sensitivity C-reactive Protein: Results From the ELEVATE UC Clinical ProgramVipul Jairath, David T Rubin, Bram Verstockt, et al.
BMJ Global Health|May 29, 2023
Effect of a mobile app chatbot and an interactive small-group webinar on COVID-19 vaccine intention and confidence in Japan: a randomised controlled trialTakaaki Kobayashi, Hana Tomoi, Yuka Nishina, et al.
Bioorganic & Medicinal Chemistry Letters|February 13, 2007
Optimization of 1,4-diazepan-2-one containing dipeptidyl peptidase IV inhibitors for the treatment of type 2 diabetesGui-Bai Liang, Xiaoxia Qian, Dennis Feng, et al.
Vaccines|July 29, 2023
Coronavirus Disease 2019 (COVID-19) Reinfection Rates in Malawi: A Possible Tool to Guide Vaccine Prioritisation and Immunisation PoliciesMaster R O Chisale, Frank Watson Sinyiza, Paul Uchizi Kaseka, et al.
Trials|October 13, 2017
The added value of a mobile application of Community Case Management on referral, re-consultation and hospitalization rates of children aged under 5 years in two districts in Northern Malawi: study protocol for a pragmatic, stepped-wedge cluster-randomized controlled trialVictoria Hardy, Yvonne O'Connor, Ciara Heavin, et al.
Patterns (New York, N.Y.)|September 5, 2024
Concepts and applications of digital twins in healthcare and medicineKang Zhang, Hong-Yu Zhou, Daniel T Baptista-Hon, et al.
Advances in Rheumatology (London, England)|December 19, 2024
Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitisAtul Deodhar, Servet Akar, Jeffrey R Curtis, et al.
The Lancet. Gastroenterology & Hepatology|May 17, 2025
Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trialEvan S Dellon, Margaret H Collins, Albert J Bredenoord, et al.
Pageof 12